Yan PW - Search Results

1

Clinical comparison of safety and efficacy of vinorelbine/epirubicin (NE) with fluorouracil/epirubicin/cyclophosphamide (FEC).

Yan PW, Huang XE, Jiang Y, Tang JH, Xu HX, Xu X, Jin X. Yan PW, et al. Asian Pac J Cancer Prev. 2010;11(4):1115-8. Asian Pac J Cancer Prev. 2010. PMID: 21133634 Free article. Clinical Trial.

2

Validation of treatment efficacy of a computer-assisted program for breast cancer patients receiving postoperative adjuvant chemotherapy.

Jiang Y, Huang XE, Yan PW, Cui L, Tang JH, Xiang J. Jiang Y, et al. Among authors: yan pw. Asian Pac J Cancer Prev. 2010;11(4):1059-62. Asian Pac J Cancer Prev. 2010. PMID: 21133624 Free article.

3

Efficacy and safety of endostar combined with chemotherapy in patients with advanced solid tumors.

Li Y, Huang XE, Yan PW, Jiang Y, Xiang J. Li Y, et al. Among authors: yan pw. Asian Pac J Cancer Prev. 2010;11(4):1119-23. Asian Pac J Cancer Prev. 2010. PMID: 21133635 Free article. Clinical Trial.

4

Influence of MDR1 gene codon 3435 polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancer.

Yan PW, Huang XE, Yan F, Xu L, Jiang Y. Yan PW, et al. Asian Pac J Cancer Prev. 2011;12(9):2291-4. Asian Pac J Cancer Prev. 2011. PMID: 22296372 Free article.

5

MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy.

Li Y, Yan PW, Huang XE, Li CG. Li Y, et al. Among authors: yan pw. Asian Pac J Cancer Prev. 2011;12(9):2405-9. Asian Pac J Cancer Prev. 2011. PMID: 22296392 Free article.

6

Raltitrexed versus 5-fluorouracil with cisplatin and concurrent radiotherapy for locally advanced nasopharyngeal carcinoma: An open labeled, randomized, controlled, and multicenter clinical trial.

Yan P, Yin H, Guo W, Sun X, Li F, Huang S, Bian X, Wang F, Zhang F, Wang B, Zhou H, Zhou C, Yin L, Jiang X, Jiang N, Wu J, Liu J, Song D, He X. Yan P, et al. Cancer Med. 2020 Sep;9(17):6166-6172. doi: 10.1002/cam4.3260. Epub 2020 Jul 12. Cancer Med. 2020. PMID: 32657029 Free PMC article. Clinical Trial.

7

Survival and Toxicity of Hypofractionated Intensity Modulated Radiation Therapy in 4 Gy Fractions for Unresectable Stage III Non-Small Cell Lung Cancer.

Kong C, Zhu X, Shi M, Wang L, Chen C, Tao H, Jiang N, Yan P, Zhao L, Song X, He X. Kong C, et al. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):710-719. doi: 10.1016/j.ijrobp.2020.03.038. Epub 2020 Apr 7. Int J Radiat Oncol Biol Phys. 2020. PMID: 32275994 Clinical Trial.

8

Prognostic value of chemotherapy in addition to concurrent chemoradiotherapy in T3-4N0-1 nasopharyngeal carcinoma: a propensity score matching study.

Wu LR, Yu HL, Jiang N, Jiang XS, Zong D, Wen J, Huang L, Xie P, Chen W, Wang TT, Gu DY, Yan PW, Yin L, He X. Wu LR, et al. Among authors: yan pw. Oncotarget. 2017 Aug 7;8(44):76807-76815. doi: 10.18632/oncotarget.20014. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100350 Free PMC article.

9

Protective properties of Huperzine A through activation Nrf2/ARE-mediated transcriptional response in X-rays radiation-induced NIH3T3 cells.

Zhu HF, Yan PW, Wang LJ, Liu YT, Wen J, Zhang Q, Fan YX, Luo YH. Zhu HF, et al. Among authors: yan pw. J Cell Biochem. 2018 Nov;119(10):8359-8367. doi: 10.1002/jcb.26919. Epub 2018 Jun 22. J Cell Biochem. 2018. PMID: 29932247

10

Tumor-suppressive microRNA-10a inhibits cell proliferation and metastasis by targeting Tiam1 in esophageal squamous cell carcinoma.

Liu Y, Wang X, Jiang X, Yan P, Zhan L, Zhu H, Wang T, Wen J. Liu Y, et al. J Cell Biochem. 2019 May;120(5):7845-7857. doi: 10.1002/jcb.28059. Epub 2018 Nov 13. J Cell Biochem. 2019. PMID: 30426564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters